While research has determined that there is no association between having AMD and then developing Alzheimer's or dementia, ...

Alzheimer’s disease doesn’t have a cure, meaning no treatment can reverse the damage that’s already occurred in the brain.

A groundbreaking study by researchers at the Queensland Brain Institute reveals that low-intensity ultrasound therapy can ...

A new study conducted by researchers from the Washington University School of Medicine identified an experimental drug that ...

Hackman died of heart disease with complications from Alzheimer’s disease a full week after a rare, rodent-borne disease took ...

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

Alzheimer's blood tests show accuracy gaps across populations, raising concerns about reliable diagnosis and healthcare inequality.

Several groundbreaking studies have examined the connection between hearing loss and Alzheimer’s risk: A Johns Hopkins ...

A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical ...

Scientists have been developing and refining methods to accurately measure the age and health of our brains, without cutting ...

Washington University School of Medicine led a study evaluating long-term gantenerumab treatment in individuals with ...